Abstract
We previously reported that susceptibility to childhood B cell precursor ALL (BCP ALL) is associated with HLA-DPB1 alleles having glutamic acid (E) rather than lysine (K) in the P4 antigenic peptide-binding pocket. Clustering ∼90% of DPB1 alleles into DPB69E (DP2, 6, 8) and DPB69K (DP1, 3, 4) supertypes revealed that DP2 and DP8 are associated with BCP ALL, but DP6 is also associated with non-BCP leukaemia. Here, we report that only one of seven alleles with the DP6 supertype (DPB1*0601) is associated with childhood leukaemia (leukaemia vs controls: odds ratio, 95% confidence interval [OR, CI]: 4.6, 2.0–10.4; corrected P=0.019), but not with childhood solid tumours or lymphomas. DPB1*0601 is also significantly associated with leukaemia subtypes, including BCP ALL, Pro-B ALL, T-ALL and AML. DPB1*0601 is significantly over-transmitted (76.9%) from parents to children with BCP ALL (OR; CI: 4.7; 1.01–22.2). Sequencing the coding region of DPB1*0601 revealed an exon 1–4 haplotype [T-DEAV-KIL-RVI] shared with DPB1*0301 and 0901, but no evidence of germline mutations in childhood leukaemia. These results suggest that the DPβ0601 molecule may be functionally involved in childhood leukaemia. Analysis of peptide binding and T-cell activation by DPβ0601-peptide complexes should help determine its role in childhood leukaemia causation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94: 13950–13954.
Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999; 354: 1499–1503.
Greaves MF, Wiemels J . Origins of chromosomal translocations in childhood leukaemia. Nature Rev Cancer 2003; 3: 639–649.
McHale CM, Smith MT . Prenatal origin of chromosomal translocations in acute childhood leukaemia: implications and future directions. Am J Hematol 2004; 75: 254–257.
Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Nat Acad Sci 2002; 99: 8242–8247.
Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M . Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 1999; 94: 1057–1062.
MacKenzie J, Gallagher A, Clayton RA, Perry J, Eden OB, Ford AM et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia 2001; 15: 415–421.
MacKenzie J, Greaves MF, Eden TO, Clayton RA, Perry J, Wilson KS et al. The putative role of transforming viruses in childhood acute lymphoblastic leukemia. Haematologica 2006; 91: 240–243.
Greaves M . Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193–203.
Gustafsson B, Bogdanovic G . Specific viruses were not detected in Guthrie cards from children who later developed leukemia. Pediatr Hematol Oncol 2007; 24: 607–613.
O'Connor SM, Boneva RS . Infectious etiologies of childhood leukemia: plausibility and challenges to proof. Environ Health Perspect 2007; 115: 146–150.
Pagano JS, Blaser M, Buendia M-A, Damania B, Khalili K, Raab-Traub N et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 453–471.
Nevels M, Täuber B, Spruss T, Wolf H, Dobner T . ‘Hit-and-run’ transformation by adenovirus oncogenes. J Virol 2001; 75: 3089–3094.
Shen Y, Zhu H, Shenk T . Human cytomegalovirus IE1 and IE2 are mutagenic and mediate ‘hit-and-run’ oncogenic transformation in cooperation with adenovirus E1A proteins. Proc Natl Acad Sci USA 1997; 94: 3341–3345.
De Visser KE, Eichten A, Coussens LM . Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6: 24–37.
Johansson M, DeNardo DG, Coussens LM . Polarized immune responses differentially regulate cancer development. Immunol Reviews 2008; 222: 145–154.
Cooke GS, Hill AVS . Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 967–977.
Martin MP, Carrington M . Immunogenetics of viral infections. Curr Opin Immunol 2005; 17: 510–516.
Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK et al. Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889–899.
Germain RN . MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287–299.
Madden DR . The three-dimensional structure of peptide-MHC complexes. Ann Reviews Immunol 1995; 13: 587–622.
Hammer J, Sturniolo T, Sinigaglia F . HLA class II peptide binding specificity and autoimmunity. Adv Immunol 1997; 66: 67–100.
Taylor GM, Dearden S, Ravetto P, Ayres M, Watson P, Hussain A, et al., UKCCS Investigators. Genetic susceptibility to childhood common acute paediatric lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Hum Mol Genet 2002; 11: 1585–1597.
Taylor M, Harrison C, Eden T, Birch J, Greaves M, Lightfoot T et al. HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention. Cancer Immunol Immunother 2008; 57: 53–61.
Taylor GM, Hussain A, Lightfoot TJ, Birch JM, Eden TOB, Greaves MF, on behalf of UKCCS Investigators. HLA-associated susceptibility to childhood B cell precursor ALL: definition and role of HLA-DPB1-supertypes. Br J Cancer 2008; 98: 1125–1131.
De Koster HS, Kenter MJH, D'Amaro J, Luiten RM, Schroeijers WEWM, Giphart MJ et al. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules. Immunogenetics 1991; 34: 12–22.
Doytchinova IA, Flower DR . In silico identification of supertypes for class II MHCs. J Immunol 2005; 174: 7085–7095.
UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer 2000; 82: 1073–1102.
Harrison CJ, Martineau M, Secker-Walker LM . The Leukaemia Research Fund /United Kingdom Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Hematol 2001; 113: 3–10.
Neitzel H . A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986; 73: 320–326.
Rozemuller EH, Eliaou JF, Baxter-Low LA, Charron D, Kronick M, Tilanus MG . An evaluation of a multicenter study on HLA-DPB1 typing using solid-phase Taq-cycle sequencing chemistry. Tissue Antigens 1995; 46: 96–103.
Goodridge D . User Guide Assign-SBT version 3.2.7: Conexio Genomics. http://www.conexio.iinet.net.au/, 2004.
Reinders J, Rozemuller EH, van Gent R, Arts-Hilkes YHA, van den Tweel JG et al. Extended HLA-DPB1 polymorphism: an RNA approach for HLA-DP1 typing. Immunogenetics 2005; 57: 790–794.
Dudbridge F . Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 2008; 66: 87–98.
Diaz G, Amicosante M, Jaraquemada D, Butler RH, Guillen MV, Sanchez M et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPβ residues 9,11,35,55,56,69,84–87 in T cell allorecognition and peptide binding. Int Immunol 2003; 15: 565–576.
Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D . Human leukocyte antigen class II amino acid epitopes. Susceptibility and progression markers for beryllium hypersensitivity. Am J Crit Care Med 2002; 165: 788–794.
McCanlies EC, Kreiss K, Andrew M, Weston A . HLA-DPB1 and chronic beryllium disease: A HuGE review. Am J Epidemiol 2003; 157: 388–398.
Ueki A, Isozaki Y, Kusaka M . Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles. J Occup Health 2005; 47: 61–67.
Rihs HP, Conrad K, Mehlhorn J, May-Taube K, Welticke B et al. Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis. Int Arch Allergy Immunol 1996; 109: 216–222.
Ottman OG, Nocka KH, Moore MA, Pelus LM . Differential expression of class II MHC antigens subpopulations of human haemopoietic progenitor cells. Leukemia 1988; 2: 677–686.
Labuda D, Krajinovic M, Sabbagh A, Infante-Rivard C, Sinnett D . Parental genotypes in the risk of a complex disease. Am J Hum Genet 2002; 71: 193–197.
OMIM: Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM [first accessed April 2007].
Nagata T, Weiss EH, Abe K, Kitagawa K, Ando A, Yara-Kikuti Y et al. Physical mapping of the retinoid X receptor B gene in mouse and human. Immunogenetics 1995; 41: 83–90.
Rajsbaum R, Fici D, Fraser PA, Flores-Villanueva PO, Awdeh ZL . Polymorphism of the human retinoid X receptor β and linkage disequilbrium with HLA-DPB1. Tissue Antigens 2001; 58: 24–29.
Rajsbaum R, Fici D, Boggs DA, Fraser PA, Flores-Villanueva PO, Awdeh ZL . Linkage disequilibrium between HLA-DPB1 alleles and retinoid X receptor β haplotypes. Hum Immunol 2002; 63: 771–778.
Grenningloh R, Gho A, di Lucia P, Klaus M, Bollag W, Ho I-C et al. Cutting Edge: Inhibition of the retinoid X receptor (RXR) blocks T helper 2 differentiation and prevents allergic lung inflammation. J Immunol 2006; 176: 5161–5171.
Stephenson CB, Rasooly R, Jiang X, Ceddia MA, Weaver CT, Chandraratna RAS et al. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol 2002; 168: 4495–4503.
Wen W, Shu XO, Linet MS, Neglia JP, Potter JD, Trigg ME et al. Allergic disorders and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2000; 11: 303–307.
Schüz J, Morgan G, Böhler E, Kaatsch P, Michaelis J . Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003; 105: 255–260.
Hughes AM Lightfoot T, Simpson J, Ansell P, McKinney PA, Kinsey SE, Mitchell CD et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 2007; 121: 819–824.
Acknowledgements
This study was funded by grants from the Kay Kendall Leukaemia Fund (to GMT), by support from Cancer Research UK (JMB), and by the Leukaemia Research Fund (TL, CJH). We are indebted to the children and families who took part in the UK Childhood Cancer Study for enabling us to carry out this work. We thank J Simpson and Professor E Roman at the Epidemiology & Genetics Unit, University of York for providing diagnostic and other information for UKCCS cases, Mrs R Carter for blood sample documentation and the midwives at St Mary's Hospital, Manchester for cord blood samples. We are grateful to MD Robinson, Dr C Watson, Dr DA Gokhale, SP Dearden for sample processing, and DPB1 typing. A complete list of UKCCS investigators is given in: UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer 2000; 82: 1073–1102.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Taylor, G., Hussain, A., Verhage, V. et al. Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601. Leukemia 23, 863–869 (2009). https://doi.org/10.1038/leu.2008.374
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.374
Keywords
This article is cited by
-
Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients
Oncogene (2019)
-
A causal mechanism for childhood acute lymphoblastic leukaemia
Nature Reviews Cancer (2018)
-
Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?
Molecular and Cellular Pediatrics (2017)
-
HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial
Blood Cancer Journal (2012)
-
Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL)
International Journal of Hematology (2012)